Fadogia Agrestis.
May offer a mild boost to libido and exercise performance. A West African shrub stem taken for libido and drive. Interest comes from rodent work where saponin-rich extract raised testosterone, and that hasn't been repeated in people.
Reviewed March 2026
- Category
- Herb
- Also filed under
- May increase libidoMay improve exercise performance
What Fadogia Agrestis is, and what it does.
- Does it work
- Suits men curious about the rodent-derived angle on drive who already have sleep, training and zinc and vitamin D status covered. Human trial evidence doesn't exist yet.
- How much to take
- Start with 200 to 600mg a day of the stem extract. No human trial has set a dose, so keep to the label amount and run it in short cycles rather than continuously.
- Time to feel it
- Nobody has measured onset in people. Users typically run it two to four weeks, which is roughly the timeline the rodent work used.
- The first dose
- Day one is quiet. The rodent work that drew attention here ran over weeks, so nothing has been documented in people from a single serving.
- With regular use
- There's no long-term human data. Common practice is short cycles with a break rather than continuous use, and that caution comes from the rodent toxicity findings.
- How well tolerated
- Human safety data doesn't exist yet. Rodent work at higher amounts reported liver and testicular damage, so keep to the label amount and talk to your doctor first.
- How it feels
- Reports are mixed and personal. Some men describe more drive inside a couple of weeks, others describe no change. No controlled trial has recorded the subjective side.
- The overlooked benefit
- It's gathered wild, not farmed, so species identity is the real quality question. A certificate showing botanical identity testing tells you more than an extract ratio.
200 to 600mg a day is where Fadogia Agrestis works.
Source: Yakubu et al. 2005 Asian J Androl (rat study); no human RCTs as of 2026
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
Animal studies suggest potential benefits on testosterone and sexual function, but human data is scarce and lacks strong support. The mechanism of action is not fully understood, and long-term safety is unknown.
- Libido and sexual behaviourAnimal study
- Testosterone already in the normal rangeAnimal study
- Exercise performance and driveNarrative review
- Organ toxicity markers at higher intakesAnimal study
Questions people ask about Fadogia Agrestis.
- When should I take it?
- Timing matters less than consistency. Pick a time that works for you and take it daily.
- Can I take it with other supplements?
- Usually fine. The main thing to watch is not doubling up on the same ingredient from different products. If you're on prescription meds, check with your pharmacist first.
- Any side effects to watch for?
- Most people tolerate it well at recommended doses. GI upset is the most common complaint with any supplement. Start with a lower dose and work up. If something feels off, stop and reassess.
- Who benefits most from this?
- Honestly, most people would benefit more from the basics. But if you've got a specific reason to try it, the risk is generally low.
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
Fadogia is reported in animal work to act on the pituitary side of the hormonal axis while eurycomanone from tongkat ali acts on sex hormone binding globulin and steroidogenic enzymes. Nearly every commercial fadogia product pairs the two on that division.
Zinc is a required cofactor in testicular steroidogenic enzymes and in the aromatase step that converts androgen to oestrogen. A botanical acting on hormonal signalling still needs mineral substrate for those enzymes.
Boron acts on the binding side by lowering sex hormone binding globulin, shifting the free-to-bound ratio. That is a distribution effect rather than a production one, so it does not overlap with fadogia.
Vitamin D receptors are expressed in testicular Leydig cells and in the pituitary, and adequate status supports normal androgen production. It underpins the axis a fadogia formula is aimed at.
Ashwagandha works on the cortisol side of the stress axis, and cortisol restrains gonadal signalling from above. Managing the suppressor is a different lever from acting on the axis directly.
Magnesium weakens the binding affinity of sex hormone binding globulin for testosterone, nudging the free fraction upward. It is a distribution effect that sits beside rather than duplicates fadogia's reported action.
Fadogia's animal literature reports markers of oxidative stress in liver and testicular tissue at higher doses, and NAC supplies cysteine as the rate-limiting substrate for glutathione. Formulators include it on that basis.
Rhodiola is combined with Fadogia in performance-oriented botanical stacks, contributing rosavins and salidroside, an unrelated chemical class. There is no shared pathway established between them and no joint human data. The rationale is commercial formulation practice.
L-citrulline is converted to arginine and raises substrate availability for nitric oxide synthase, a defined and separate mechanism. Fadogia has no characterised action on that pathway in published human work. They are combined in the same products, which is not the same as acting together.
Arginine is the direct substrate for nitric oxide synthase and is a common co-ingredient in the same category of formulas. Its mechanism is established; Fadogia's is not characterised in people. Any combined claim would rest entirely on the arginine side.
Creatine has a well-described role in phosphocreatine buffering during short intense effort, unrelated to anything characterised for Fadogia. The two appear in the same performance stacks. Read the pairing as product design, not as an interaction.
Maca contributes glucosinolates and macamides and is combined with Fadogia in the same product category. The two botanicals have no established shared mechanism. This row records that they co-occur, nothing more.
Fenugreek seed carries steroidal saponins such as diosgenin-type glycosides, the same broad class characterised in Fadogia stem. Both appear in the same category of blends for that reason. The shared class is chemistry, not evidence of a joint effect.
Shilajit is a mineral-humic exudate with fulvic acid content, chemically unlike the saponins in Fadogia. The two are combined in the same commercial stacks. There is no published combination work.
Silymarin from milk thistle is used as a hepatic-support ingredient in many botanical stacks, and Fadogia products commonly include it. Published human data on Fadogia is extremely limited, with rodent work being most of what exists, so this pairing is a formulation habit rather than a characterised interaction. Anyone using it should be doing so with a clinician's input.
Vitamin D is a nutrient with an established endocrine role and is included in the same blends for that separate reason. Fadogia contributes plant saponins with no characterised endocrine pathway in humans. Their co-occurrence on a label reflects category design.
Talk to a doctor before taking Fadogia Agrestis if any of these apply to you: May interact with medications, Potential hormone disruption, Limited human safety data. These are flags to check first, not effects Fadogia Agrestis is known to cause.
Not medical advice. Show the label to your pharmacist.What Fadogia Agrestis actually does.
Saponins are big sugar-coated molecules that barely cross the gut wall intact. Your gut bugs usually strip the sugars off first, so what reaches your blood isn't the compound printed on an analysis certificate.
Saponins act like soap by structure, which is why saponin-rich plant extracts foam when you shake them in water, and why lab studies describe them as membrane-interacting compounds.
A ten to one concentrate tells you how much raw stem went into a kilogram of finished powder. It says nothing about how much of any named constituent is in there, so two products at the same ratio aren't the same material.
The stem carries triterpenoid saponins alongside alkaloids and flavonoids. The saponin fraction is the part the published rodent work pinned the activity on.
Where Fadogia Agrestis comes from.
It comes from the woody stems of a shrub that grows wild in West Africa, mostly gathered rather than farmed. The stems are dried, milled and soaked to pull the plant chemistry out, then that liquid is dried into a powder for capsules. Because it is wild-collected, checking that the plant really is the right species is the part that matters most.
Made from a plant. What ends up in the capsule tracks the harvest, so batch testing and a stated marker matter more here than with a made molecule.
A shrub of West African savannah, principally Nigeria, with the stem being the part used. Material is largely wild-collected rather than cultivated, which is why botanical identity checks matter for this ingredient more than for a farmed herb.
Stems are dried and milled to a coarse powder before extraction.
Water or aqueous ethanol pulls the saponin and alkaloid fractions from the milled stem.
Solids are filtered off and the extract is concentrated under reduced pressure.
Declared either as a herb-to-extract ratio or against a total saponin figure. Species identity should be confirmed by botanical or DNA methods, since related Fadogia species and adulterants exist in the trade.
Spray dried onto a carrier and encapsulated.
Getting Fadogia Agrestis from food.
The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
The forms it comes in.
The essence, in one line each.
- A review of the ingredients used in testosterone-boosting supplements found that most of them, Fadogia agrestis among them, had no human data behind the testosterone claims made for them.Systematic review. Clemesha et al., 2020 (The world journal of men's health). PMID 31385468 ↗
These are the studies our verdict leans on, chosen from the 1 we read for Fadogia Agrestis. The full linked list is below.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.
